entertainment -WSS

entertainment

author：fashion 2025-08-25 07:29:32 - browse：2

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： A cyberattack has disrupted hospitals and health care in several states

hotspot

WSS

Neuroscience startup Neumora files for IPO

Verily hires former Apple Health leader as chief scientific officer

What do new weight loss drugs mean for bariatric surgery?

Appeals court upholds limits to abortion pill

Microsoft strikes partnership with Duke Health to advance health AI

Humana, CVS hope to turn members into patients at clinics

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

ProMED, early warning system on disease outbreaks, in peril

Trump demands the U.S. pay no more for drugs than other countries … again

In science, is the line between industry and academia shifting?

In age of alternative facts, a scholarly course on calling out crap

Neuroscience startup Neumora files for IPO

Medical records are filled with copy

Medicare explains how it will choose drugs for negotiation

Bright Health sells Medicare Advantage business to Molina

OTC birth control: A brief history of over the counter pill design

leisure time

My superpower is killing ticks

Winners, losers from Medicare’s list of drugs subject to price talks

CDC advisory panel says seniors 'may' get RSV vaccine

Attacks on the drug industry will lead to fewer breakthroughs

How to make Best Hospitals ratings actually useful for patients

FDA panel gives mixed vote on blood pressure devices

hotspot

hotspot

hotspot

explore